Association of Functional Heme Oxygenase‐1 Gene Promoter Polymorphism with Renal Transplantation Outcomes

Heme oxygenase‐1 (HO‐1) is a cytoprotective molecule and increased expression in experimental transplant models correlates with reduced graft injury. A functional dinucleotide repeat (GT)n polymorphism, within the HO‐1 promoter, regulates gene expression; a short number of repeats (S‐allele

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:American journal of transplantation 2007-04, Vol.7 (4), p.908-913
Hauptverfasser: Courtney, A. E., McNamee, P. T., Middleton, D., Heggarty, S., Patterson, C. C., Maxwell, A. P.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 913
container_issue 4
container_start_page 908
container_title American journal of transplantation
container_volume 7
creator Courtney, A. E.
McNamee, P. T.
Middleton, D.
Heggarty, S.
Patterson, C. C.
Maxwell, A. P.
description Heme oxygenase‐1 (HO‐1) is a cytoprotective molecule and increased expression in experimental transplant models correlates with reduced graft injury. A functional dinucleotide repeat (GT)n polymorphism, within the HO‐1 promoter, regulates gene expression; a short number of repeats (S‐allele
doi_str_mv 10.1111/j.1600-6143.2006.01726.x
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_70315152</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>21056091</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4786-fede25d26c6db2aa42702153e35c23410d01b3135095108f2628a17fc1ab5b5d3</originalsourceid><addsrcrecordid>eNqNkU1u2zAQhYmiRfPTXiHgpt1ZnSFNSl50YQT5KwI4CNw1QVGjRo4kOqSE2LseoWfMSSLVRrJMuOEA_N7M8D3GOEKCw_mxSlADTDROZSIAdAKYCp1sPrDDl4ePL7VUB-woxhWMVCY-swNM5QxRykN2P4_Ru8p2lW-5L_l537qxtjW_pIb4YrP9Q62N9PT3H_ILaonfBN_4jgK_8fW28WF9V8WGP1bdHb-lUbgMto3r2rbdru2i75xvKH5hn0pbR_q6v4_Z7_Oz5enl5HpxcXU6v564aZrpSUkFCVUI7XSRC2unIgWBSpJUTsgpQgGYy-FXMFMIWSm0yCympUObq1wV8ph93_VdB__QU-xMU0VH9bAR-T6aFCQqVOJNUCAoDTMcwGwHuuBjDFSadagaG7YGwYyJmJUZzTaj8WZMxPxPxGwG6cl-Rp83VLwK9xEMwLc9YKOzdTmY56r4ymUpoAIYuJ877rGqafvuBcz813Ks5DPg5ae6</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>21056091</pqid></control><display><type>article</type><title>Association of Functional Heme Oxygenase‐1 Gene Promoter Polymorphism with Renal Transplantation Outcomes</title><source>MEDLINE</source><source>Access via Wiley Online Library</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Courtney, A. E. ; McNamee, P. T. ; Middleton, D. ; Heggarty, S. ; Patterson, C. C. ; Maxwell, A. P.</creator><creatorcontrib>Courtney, A. E. ; McNamee, P. T. ; Middleton, D. ; Heggarty, S. ; Patterson, C. C. ; Maxwell, A. P.</creatorcontrib><description>Heme oxygenase‐1 (HO‐1) is a cytoprotective molecule and increased expression in experimental transplant models correlates with reduced graft injury. A functional dinucleotide repeat (GT)n polymorphism, within the HO‐1 promoter, regulates gene expression; a short number of repeats (S‐allele &lt;25) increases transcription. The role of this HO‐1 gene promoter polymorphism on renal transplant outcomes was assessed. DNA from 707 donor/recipient pairs (n = 1414) of first deceased donor renal transplants (99% Caucasian) was genotyped. Graft survival was not significantly impacted by carriage of an S‐allele by the donor (hazard ratio 0.89, 95% CI 0.71–1.11; p = 0.28) or recipient (hazard ratio 1.19, 95% CI 0.95–1.48; p = 0.13). Similarly neither donor nor recipient genotype influenced recipient survival (hazard ratio 0.89, 95% CI 0.67–1.18; p = 0.41, and hazard ratio 1.22, 95% CI 0.93–1.62; p = 0.16). The hazard ratios changed only minimally in multivariate analysis including significant survival factors. Genotype did not alter the incidence of acute rejection or chronic allograft nephropathy. There is no evidence of a protective effect for the S‐allele of the HO‐1 gene promoter polymorphism on graft or recipient survival in clinical renal transplantation. The graft and recipient survival of 707 first deceased donor renal transplants was not significantly influenced by the (GT)n length polymorphism of the HO‐1 gene promoter.</description><identifier>ISSN: 1600-6135</identifier><identifier>EISSN: 1600-6143</identifier><identifier>DOI: 10.1111/j.1600-6143.2006.01726.x</identifier><identifier>PMID: 17391133</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Publishing Ltd</publisher><subject>Adult ; Biological and medical sciences ; Cadaver ; Dinucleotide Repeats - genetics ; DNA - genetics ; DNA - isolation &amp; purification ; Female ; Genotype ; Graft Survival - physiology ; Heme oxygenase ; Heme Oxygenase-1 - genetics ; Humans ; kidney transplantation ; Kidney Transplantation - mortality ; Kidney Transplantation - physiology ; Male ; Medical sciences ; Polymerase Chain Reaction ; Polymorphism, Genetic ; Prevention and actions ; Promoter Regions, Genetic ; protective genes ; Public health. Hygiene ; Public health. Hygiene-occupational medicine ; Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases ; Surgery of the urinary system ; Survival Analysis ; Tissue Donors ; transplant outcomes ; Treatment Outcome</subject><ispartof>American journal of transplantation, 2007-04, Vol.7 (4), p.908-913</ispartof><rights>2007 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4786-fede25d26c6db2aa42702153e35c23410d01b3135095108f2628a17fc1ab5b5d3</citedby><cites>FETCH-LOGICAL-c4786-fede25d26c6db2aa42702153e35c23410d01b3135095108f2628a17fc1ab5b5d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fj.1600-6143.2006.01726.x$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fj.1600-6143.2006.01726.x$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1417,27924,27925,45574,45575</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=18701500$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17391133$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Courtney, A. E.</creatorcontrib><creatorcontrib>McNamee, P. T.</creatorcontrib><creatorcontrib>Middleton, D.</creatorcontrib><creatorcontrib>Heggarty, S.</creatorcontrib><creatorcontrib>Patterson, C. C.</creatorcontrib><creatorcontrib>Maxwell, A. P.</creatorcontrib><title>Association of Functional Heme Oxygenase‐1 Gene Promoter Polymorphism with Renal Transplantation Outcomes</title><title>American journal of transplantation</title><addtitle>Am J Transplant</addtitle><description>Heme oxygenase‐1 (HO‐1) is a cytoprotective molecule and increased expression in experimental transplant models correlates with reduced graft injury. A functional dinucleotide repeat (GT)n polymorphism, within the HO‐1 promoter, regulates gene expression; a short number of repeats (S‐allele &lt;25) increases transcription. The role of this HO‐1 gene promoter polymorphism on renal transplant outcomes was assessed. DNA from 707 donor/recipient pairs (n = 1414) of first deceased donor renal transplants (99% Caucasian) was genotyped. Graft survival was not significantly impacted by carriage of an S‐allele by the donor (hazard ratio 0.89, 95% CI 0.71–1.11; p = 0.28) or recipient (hazard ratio 1.19, 95% CI 0.95–1.48; p = 0.13). Similarly neither donor nor recipient genotype influenced recipient survival (hazard ratio 0.89, 95% CI 0.67–1.18; p = 0.41, and hazard ratio 1.22, 95% CI 0.93–1.62; p = 0.16). The hazard ratios changed only minimally in multivariate analysis including significant survival factors. Genotype did not alter the incidence of acute rejection or chronic allograft nephropathy. There is no evidence of a protective effect for the S‐allele of the HO‐1 gene promoter polymorphism on graft or recipient survival in clinical renal transplantation. The graft and recipient survival of 707 first deceased donor renal transplants was not significantly influenced by the (GT)n length polymorphism of the HO‐1 gene promoter.</description><subject>Adult</subject><subject>Biological and medical sciences</subject><subject>Cadaver</subject><subject>Dinucleotide Repeats - genetics</subject><subject>DNA - genetics</subject><subject>DNA - isolation &amp; purification</subject><subject>Female</subject><subject>Genotype</subject><subject>Graft Survival - physiology</subject><subject>Heme oxygenase</subject><subject>Heme Oxygenase-1 - genetics</subject><subject>Humans</subject><subject>kidney transplantation</subject><subject>Kidney Transplantation - mortality</subject><subject>Kidney Transplantation - physiology</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Polymerase Chain Reaction</subject><subject>Polymorphism, Genetic</subject><subject>Prevention and actions</subject><subject>Promoter Regions, Genetic</subject><subject>protective genes</subject><subject>Public health. Hygiene</subject><subject>Public health. Hygiene-occupational medicine</subject><subject>Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases</subject><subject>Surgery of the urinary system</subject><subject>Survival Analysis</subject><subject>Tissue Donors</subject><subject>transplant outcomes</subject><subject>Treatment Outcome</subject><issn>1600-6135</issn><issn>1600-6143</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkU1u2zAQhYmiRfPTXiHgpt1ZnSFNSl50YQT5KwI4CNw1QVGjRo4kOqSE2LseoWfMSSLVRrJMuOEA_N7M8D3GOEKCw_mxSlADTDROZSIAdAKYCp1sPrDDl4ePL7VUB-woxhWMVCY-swNM5QxRykN2P4_Ru8p2lW-5L_l537qxtjW_pIb4YrP9Q62N9PT3H_ILaonfBN_4jgK_8fW28WF9V8WGP1bdHb-lUbgMto3r2rbdru2i75xvKH5hn0pbR_q6v4_Z7_Oz5enl5HpxcXU6v564aZrpSUkFCVUI7XSRC2unIgWBSpJUTsgpQgGYy-FXMFMIWSm0yCympUObq1wV8ph93_VdB__QU-xMU0VH9bAR-T6aFCQqVOJNUCAoDTMcwGwHuuBjDFSadagaG7YGwYyJmJUZzTaj8WZMxPxPxGwG6cl-Rp83VLwK9xEMwLc9YKOzdTmY56r4ymUpoAIYuJ877rGqafvuBcz813Ks5DPg5ae6</recordid><startdate>200704</startdate><enddate>200704</enddate><creator>Courtney, A. E.</creator><creator>McNamee, P. T.</creator><creator>Middleton, D.</creator><creator>Heggarty, S.</creator><creator>Patterson, C. C.</creator><creator>Maxwell, A. P.</creator><general>Blackwell Publishing Ltd</general><general>Blackwell</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope><scope>RC3</scope><scope>7X8</scope></search><sort><creationdate>200704</creationdate><title>Association of Functional Heme Oxygenase‐1 Gene Promoter Polymorphism with Renal Transplantation Outcomes</title><author>Courtney, A. E. ; McNamee, P. T. ; Middleton, D. ; Heggarty, S. ; Patterson, C. C. ; Maxwell, A. P.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4786-fede25d26c6db2aa42702153e35c23410d01b3135095108f2628a17fc1ab5b5d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>Adult</topic><topic>Biological and medical sciences</topic><topic>Cadaver</topic><topic>Dinucleotide Repeats - genetics</topic><topic>DNA - genetics</topic><topic>DNA - isolation &amp; purification</topic><topic>Female</topic><topic>Genotype</topic><topic>Graft Survival - physiology</topic><topic>Heme oxygenase</topic><topic>Heme Oxygenase-1 - genetics</topic><topic>Humans</topic><topic>kidney transplantation</topic><topic>Kidney Transplantation - mortality</topic><topic>Kidney Transplantation - physiology</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Polymerase Chain Reaction</topic><topic>Polymorphism, Genetic</topic><topic>Prevention and actions</topic><topic>Promoter Regions, Genetic</topic><topic>protective genes</topic><topic>Public health. Hygiene</topic><topic>Public health. Hygiene-occupational medicine</topic><topic>Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases</topic><topic>Surgery of the urinary system</topic><topic>Survival Analysis</topic><topic>Tissue Donors</topic><topic>transplant outcomes</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Courtney, A. E.</creatorcontrib><creatorcontrib>McNamee, P. T.</creatorcontrib><creatorcontrib>Middleton, D.</creatorcontrib><creatorcontrib>Heggarty, S.</creatorcontrib><creatorcontrib>Patterson, C. C.</creatorcontrib><creatorcontrib>Maxwell, A. P.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>American journal of transplantation</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Courtney, A. E.</au><au>McNamee, P. T.</au><au>Middleton, D.</au><au>Heggarty, S.</au><au>Patterson, C. C.</au><au>Maxwell, A. P.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Association of Functional Heme Oxygenase‐1 Gene Promoter Polymorphism with Renal Transplantation Outcomes</atitle><jtitle>American journal of transplantation</jtitle><addtitle>Am J Transplant</addtitle><date>2007-04</date><risdate>2007</risdate><volume>7</volume><issue>4</issue><spage>908</spage><epage>913</epage><pages>908-913</pages><issn>1600-6135</issn><eissn>1600-6143</eissn><abstract>Heme oxygenase‐1 (HO‐1) is a cytoprotective molecule and increased expression in experimental transplant models correlates with reduced graft injury. A functional dinucleotide repeat (GT)n polymorphism, within the HO‐1 promoter, regulates gene expression; a short number of repeats (S‐allele &lt;25) increases transcription. The role of this HO‐1 gene promoter polymorphism on renal transplant outcomes was assessed. DNA from 707 donor/recipient pairs (n = 1414) of first deceased donor renal transplants (99% Caucasian) was genotyped. Graft survival was not significantly impacted by carriage of an S‐allele by the donor (hazard ratio 0.89, 95% CI 0.71–1.11; p = 0.28) or recipient (hazard ratio 1.19, 95% CI 0.95–1.48; p = 0.13). Similarly neither donor nor recipient genotype influenced recipient survival (hazard ratio 0.89, 95% CI 0.67–1.18; p = 0.41, and hazard ratio 1.22, 95% CI 0.93–1.62; p = 0.16). The hazard ratios changed only minimally in multivariate analysis including significant survival factors. Genotype did not alter the incidence of acute rejection or chronic allograft nephropathy. There is no evidence of a protective effect for the S‐allele of the HO‐1 gene promoter polymorphism on graft or recipient survival in clinical renal transplantation. The graft and recipient survival of 707 first deceased donor renal transplants was not significantly influenced by the (GT)n length polymorphism of the HO‐1 gene promoter.</abstract><cop>Oxford, UK</cop><pub>Blackwell Publishing Ltd</pub><pmid>17391133</pmid><doi>10.1111/j.1600-6143.2006.01726.x</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1600-6135
ispartof American journal of transplantation, 2007-04, Vol.7 (4), p.908-913
issn 1600-6135
1600-6143
language eng
recordid cdi_proquest_miscellaneous_70315152
source MEDLINE; Access via Wiley Online Library; EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection
subjects Adult
Biological and medical sciences
Cadaver
Dinucleotide Repeats - genetics
DNA - genetics
DNA - isolation & purification
Female
Genotype
Graft Survival - physiology
Heme oxygenase
Heme Oxygenase-1 - genetics
Humans
kidney transplantation
Kidney Transplantation - mortality
Kidney Transplantation - physiology
Male
Medical sciences
Polymerase Chain Reaction
Polymorphism, Genetic
Prevention and actions
Promoter Regions, Genetic
protective genes
Public health. Hygiene
Public health. Hygiene-occupational medicine
Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases
Surgery of the urinary system
Survival Analysis
Tissue Donors
transplant outcomes
Treatment Outcome
title Association of Functional Heme Oxygenase‐1 Gene Promoter Polymorphism with Renal Transplantation Outcomes
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T13%3A01%3A23IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Association%20of%20Functional%20Heme%20Oxygenase%E2%80%901%20Gene%20Promoter%20Polymorphism%20with%20Renal%20Transplantation%20Outcomes&rft.jtitle=American%20journal%20of%20transplantation&rft.au=Courtney,%20A.%20E.&rft.date=2007-04&rft.volume=7&rft.issue=4&rft.spage=908&rft.epage=913&rft.pages=908-913&rft.issn=1600-6135&rft.eissn=1600-6143&rft_id=info:doi/10.1111/j.1600-6143.2006.01726.x&rft_dat=%3Cproquest_cross%3E21056091%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=21056091&rft_id=info:pmid/17391133&rfr_iscdi=true